Literature DB >> 3084341

Haemostatic problems in liver disease.

D A Kelly, E G Tuddenham.   

Abstract

Entities:  

Mesh:

Substances:

Year:  1986        PMID: 3084341      PMCID: PMC1433431          DOI: 10.1136/gut.27.3.339

Source DB:  PubMed          Journal:  Gut        ISSN: 0017-5749            Impact factor:   23.059


× No keyword cloud information.
  59 in total

1.  Vitamin K and the biosynthesis of prothrombin. I. Identification and purification of a dicoumarol-induced abnormal prothrombin from bovine plasma.

Authors:  J Stenflo; P O Ganrot
Journal:  J Biol Chem       Date:  1972-12-25       Impact factor: 5.157

2.  Elevation of factor VIII in acute fatal liver necrosis.

Authors:  E O Meili; P W Straub
Journal:  Thromb Diath Haemorrh       Date:  1970-10-31

3.  Behaviour of antithrombin 3 in liver disease.

Authors:  F Duckert
Journal:  Scand J Gastroenterol Suppl       Date:  1973

4.  The purification and mechanism of action of human antithrombin-heparin cofactor.

Authors:  R D Rosenberg; P S Damus
Journal:  J Biol Chem       Date:  1973-09-25       Impact factor: 5.157

5.  Multivariate analysis of clinical and biological data in cirrhotic patients: application to prognosis.

Authors:  O G Ekindjian; M Devanlay; D Duchassaing; G Leluan; J Kammerer; P Fouet; J L Auget; J Maccario
Journal:  Eur J Clin Invest       Date:  1981-06       Impact factor: 4.686

6.  Megathrombocytes, platelet regeneration time and platelet associated IgG in idiopathic thrombocytopenic purpura and in thrombocytopenia associated with chronic liver disease.

Authors:  G Leone; A Agostini; G Mango; R Landolfi; V M Valori; B Bizzi
Journal:  Acta Haematol       Date:  1981       Impact factor: 2.195

7.  Hypercoagulability in acute esophageal variceal bleeding.

Authors:  E Hiller; F Hegemann; K Possinger
Journal:  Thromb Res       Date:  1981-05-01       Impact factor: 3.944

8.  Disseminated intravascular coagulation in hepatic failure treated with antithrombin III.

Authors:  B Laursen; J Z Mortensen; L Frost; K B Hansen
Journal:  Thromb Res       Date:  1981 Jun 1-25       Impact factor: 3.944

9.  Bleeding after liver biopsy does not correlate with indices of peripheral coagulation.

Authors:  K Ewe
Journal:  Dig Dis Sci       Date:  1981-05       Impact factor: 3.199

10.  Kinetic and functional studies of platelets, fibrinogen, and plasminogen in patients with hepatic cirrhosis.

Authors:  S F Stein; L A Harker
Journal:  J Lab Clin Med       Date:  1982-02
View more
  11 in total

1.  Coagulopathy of Liver Disease.

Authors: 
Journal:  Curr Treat Options Gastroenterol       Date:  2000-12

Review 2.  New insights into the coagulopathy of liver disease and liver transplantation.

Authors:  M Senzolo; P Burra; E Cholongitas; A-K Burroughs
Journal:  World J Gastroenterol       Date:  2006-12-28       Impact factor: 5.742

3.  Acquired coagulant factor VIII deficiency induced by Bacillus anthracis lethal toxin in mice.

Authors:  Der-Shan Sun; Po-Chien Lee; Jyh-Hwa Kau; Yung-Luen Shih; Hsin-Hsien Huang; Chen-Ru Li; Chin-Cheng Lee; Yu-Ping Wu; Kuo-Ching Chen; Hsin-Hou Chang
Journal:  Virulence       Date:  2015-04-23       Impact factor: 5.882

4.  Renal and Gastrointestinal Considerations in Joint Replacement Surgery.

Authors:  Benjamin Voss; Alexander Kurdi; Alexander Skopec; Jasmine Saleh; Mouhanad M El-Othmani; Joseph M Lane; William M Mihalko; Khaled J Saleh
Journal:  J Nat Sci       Date:  2015-02-01

5.  Thrombelastographic changes and early rebleeding in cirrhotic patients with variceal bleeding.

Authors:  T N Chau; Y W Chan; D Patch; S Tokunaga; L Greenslade; A K Burroughs
Journal:  Gut       Date:  1998-08       Impact factor: 23.059

6.  Expression of LYVE-1 in sinusoidal endothelium is reduced in chronically inflamed human livers.

Authors:  Junko Arimoto; Yoshihiro Ikura; Takehisa Suekane; Masashi Nakagawa; Chizuko Kitabayashi; Yoko Iwasa; Kenichi Sugioka; Takahiko Naruko; Tetsuo Arakawa; Makiko Ueda
Journal:  J Gastroenterol       Date:  2009-11-12       Impact factor: 7.527

7.  Plasma concentrations of endogenous heparinoids in portal hypertension.

Authors:  R F McKee; S Hodson; J Dawes; O J Garden; D C Carter
Journal:  Gut       Date:  1992-11       Impact factor: 23.059

8.  Evaluation of initial heparin infusion rates for a high-dose protocol.

Authors:  Adam Smith; Eileen M Stock; Nathan Fewel; Michael Rose; Carrie L Griffiths
Journal:  J Thromb Thrombolysis       Date:  2014-05       Impact factor: 2.300

9.  Fibrinogen alpha C chain 5.9 kDa fragment (FIC5.9), a biomarker for various pathological conditions, is produced in post-blood collection by fibrinolysis and coagulation factors.

Authors:  Wataru Kikuchi; Motoi Nishimura; Takahisa Kuga; Sachio Tsuchida; Tatsuya Saito; Mamoru Satoh; Kenta Noda; Yoshio Kodera; Takeshi Tomonaga; Fumio Nomura
Journal:  Clin Proteomics       Date:  2016-10-07       Impact factor: 3.988

10.  Coagulopathy in liver disease.

Authors:  Wojciech Blonski; Timothy Siropaides; K Rajender Reddy
Journal:  Curr Treat Options Gastroenterol       Date:  2007-12
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.